277 related articles for article (PubMed ID: 33109232)
1. Differential kynurenine pathway metabolism in highly metastatic aggressive breast cancer subtypes: beyond IDO1-induced immunosuppression.
Heng B; Bilgin AA; Lovejoy DB; Tan VX; Milioli HH; Gluch L; Bustamante S; Sabaretnam T; Moscato P; Lim CK; Guillemin GJ
Breast Cancer Res; 2020 Oct; 22(1):113. PubMed ID: 33109232
[TBL] [Abstract][Full Text] [Related]
2. Understanding the role of the kynurenine pathway in human breast cancer immunobiology.
Heng B; Lim CK; Lovejoy DB; Bessede A; Gluch L; Guillemin GJ
Oncotarget; 2016 Feb; 7(6):6506-20. PubMed ID: 26646699
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations affecting the genes encoding the enzymes of the kynurenine pathway and their association with human diseases.
Boros FA; Bohár Z; Vécsei L
Mutat Res Rev Mutat Res; 2018; 776():32-45. PubMed ID: 29807576
[TBL] [Abstract][Full Text] [Related]
4. Abnormal kynurenine pathway of tryptophan catabolism in cardiovascular diseases.
Song P; Ramprasath T; Wang H; Zou MH
Cell Mol Life Sci; 2017 Aug; 74(16):2899-2916. PubMed ID: 28314892
[TBL] [Abstract][Full Text] [Related]
5. Activation of the kynurenine pathway and increased production of the excitotoxin quinolinic acid following traumatic brain injury in humans.
Yan EB; Frugier T; Lim CK; Heng B; Sundaram G; Tan M; Rosenfeld JV; Walker DW; Guillemin GJ; Morganti-Kossmann MC
J Neuroinflammation; 2015 May; 12():110. PubMed ID: 26025142
[TBL] [Abstract][Full Text] [Related]
6. Activation of the Kynurenine Pathway in Human Malignancies Can Be Suppressed by the Cyclin-Dependent Kinase Inhibitor Dinaciclib.
Riess C; Schneider B; Kehnscherper H; Gesche J; Irmscher N; Shokraie F; Classen CF; Wirthgen E; Domanska G; Zimpfer A; Strüder D; Junghanss C; Maletzki C
Front Immunol; 2020; 11():55. PubMed ID: 32117235
[TBL] [Abstract][Full Text] [Related]
7. Suppression of Kynurenine 3-Monooxygenase as a Treatment for Triple-negative Breast Carcinoma.
Sordillo LA; Sordillo PP
Anticancer Res; 2023 Dec; 43(12):5275-5282. PubMed ID: 38030171
[TBL] [Abstract][Full Text] [Related]
8. The Kynurenine Pathway as a Potential Target for Neuropathic Pain Therapy Design: From Basic Research to Clinical Perspectives.
Ciapała K; Mika J; Rojewska E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681715
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the kynurenine pathway in human glioma pathophysiology.
Adams S; Teo C; McDonald KL; Zinger A; Bustamante S; Lim CK; Sundaram G; Braidy N; Brew BJ; Guillemin GJ
PLoS One; 2014; 9(11):e112945. PubMed ID: 25415278
[TBL] [Abstract][Full Text] [Related]
10. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
11. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
[TBL] [Abstract][Full Text] [Related]
12. IDO Targeting in Sarcoma: Biological and Clinical Implications.
Nafia I; Toulmonde M; Bortolotto D; Chaibi A; Bodet D; Rey C; Velasco V; Larmonier CB; Cerf L; Adam J; Le Loarer F; Savina A; Bessede A; Italiano A
Front Immunol; 2020; 11():274. PubMed ID: 32194552
[TBL] [Abstract][Full Text] [Related]
13. Major Developments in the Design of Inhibitors along the Kynurenine Pathway.
Jacobs KR; Castellano-Gonzalez G; Guillemin GJ; Lovejoy DB
Curr Med Chem; 2017; 24(23):2471-2495. PubMed ID: 28464785
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.
Hornigold N; Dunn KR; Craven RA; Zougman A; Trainor S; Shreeve R; Brown J; Sewell H; Shires M; Knowles M; Fukuwatari T; Maher ER; Burns J; Bhattarai S; Menon M; Brazma A; Scelo G; Feulner L; Riazalhosseini Y; Lathrop M; Harris A; Selby PJ; Banks RE; Vasudev NS
Br J Cancer; 2020 Jul; 123(1):137-147. PubMed ID: 32390008
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Indoleamine-2,3-Dioxygenase and Kynurenine Pathway in Experimental Autoimmune Encephalomyelitis in Mice.
Zarzecki MS; Cattelan Souza L; Giacomeli R; Silva MRP; Prigol M; Boeira SP; Jesse CR
Neurochem Res; 2020 Dec; 45(12):2959-2977. PubMed ID: 33040279
[TBL] [Abstract][Full Text] [Related]
16. A novel causative role of imbalanced kynurenine pathway in ulcerative colitis: Upregulation of KMO and KYNU promotes intestinal inflammation.
Shi Y; Luo S; Zhai J; Chen Y
Biochim Biophys Acta Mol Basis Dis; 2024 Feb; 1870(2):166929. PubMed ID: 37918679
[TBL] [Abstract][Full Text] [Related]
17. HMGB1 mediates depressive behavior induced by chronic stress through activating the kynurenine pathway.
Wang B; Lian YJ; Su WJ; Peng W; Dong X; Liu LL; Gong H; Zhang T; Jiang CL; Wang YX
Brain Behav Immun; 2018 Aug; 72():51-60. PubMed ID: 29195782
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the kynurenine pathway in breast cancer: updates on clinical research and trials.
Girithar HN; Staats Pires A; Ahn SB; Guillemin GJ; Gluch L; Heng B
Br J Cancer; 2023 Aug; 129(2):185-203. PubMed ID: 37041200
[TBL] [Abstract][Full Text] [Related]
19. Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain.
Giorgini F; Huang SY; Sathyasaikumar KV; Notarangelo FM; Thomas MA; Tararina M; Wu HQ; Schwarcz R; Muchowski PJ
J Biol Chem; 2013 Dec; 288(51):36554-66. PubMed ID: 24189070
[TBL] [Abstract][Full Text] [Related]
20. Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas.
Vázquez Cervantes GI; Pineda B; Ramírez Ortega D; Salazar A; González Esquivel DF; Rembao D; Zavala Vega S; Gómez-Manzo S; Pérez de la Cruz G; Pérez de la Cruz V
Cells; 2021 Aug; 10(8):. PubMed ID: 34440798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
